D
Repligen Corporation RGEN
$148.73 $3.502.41% NASDAQ
Recommendation
Prev Close
$125.61
Volume
1,285,934
Avg Vol (90D)
801,451
Market Cap
$7.07B
Dividend & Yield
--
52-Week Range
$102.97 - $182.52
P/E (TTM)
--
EPS (TTM)
-$0.2614
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Can New Analyst Attention on RGEN Reveal the True Strength of Repligen's Bioprocessing Edge?
10/4/2025 - Simply Wall St
Why Investors Shouldn't Be Surprised By Repligen Corporation's (NASDAQ:RGEN) 28% Share Price Surge
10/4/2025 - Simply Wall St
Repligen (RGEN) Poised for Rebound Amid Market Shifts
10/2/2025 - GuruFocus
Repligen (RGEN, $145.81) RSI Indicator left the overbought zone on October 01, 2025
10/2/2025 - Tickeron - Stocks
Repligen price target raised by $10 at Barclays, here's why
10/2/2025 - The Fly
Analysts' Top Healthcare Picks: Maze Therapeutics, Inc. (MAZE), Repligen (RGEN)
10/2/2025 - TipRanks Financial Blog
What 8 Analyst Ratings Have To Say About Repligen
10/1/2025 - Benzinga
Best Manufacturing Stocks To Follow Today - October 1st
10/1/2025 - MarketBeat
Repligen (RGEN) Receives "Buy" Rating from HSBC with Target Price of $150 RGEN ...
10/1/2025 - GuruFocus
RGEN Crosses Above Key Moving Average Level
10/1/2025 - Market News Video
Repligen (RGEN) Gains Momentum with HSBC's Buy Rating and Strong Growth Outlook
10/1/2025 - GuruFocus
Repligen higher as HSBC initiates at Buy on growth prospects
10/1/2025 - Seeking Alpha - Healthcare
Repligen initiated with bullish view at HSBC, here's why
10/1/2025 - The Fly
Park Avenue Securities LLC Invests $340,000 in Repligen Corporation $RGEN
10/1/2025 - MarketBeat
Repligen (NASDAQ:RGEN) Trading Up 4.5% - Time to Buy?
9/30/2025 - MarketBeat
Banque Pictet & Cie SA Has $2.58 Million Position in Repligen Corporation $RGEN
9/27/2025 - MarketBeat
Repligen Corporation $RGEN Shares Bought by Congress Asset Management Co.
9/27/2025 - MarketBeat
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2025 Transcript
9/25/2025 - SeekingAlpha
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2025 Transcript
9/25/2025 - Seeking Alpha: Transcripts
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2025 - Slideshow
9/25/2025 - SeekingAlpha
How Investors May Respond To Repligen (RGEN) Beating Revenue Forecasts and Raising 2024 Guidance
9/24/2025 - Simply Wall St
Craig-Hallum Remains a Buy on Repligen (RGEN)
9/23/2025 - TipRanks Financial Blog
Repligen (RGEN) Sees Analyst Rating Upgrade and Price Target Raise RGEN Stock News
9/22/2025 - GuruFocus
Repligen upgraded to Outperform from In Line at Evercore ISI
9/22/2025 - TipRanks Financial Blog
Repligen just upgraded at Evercore ISI, here's why
9/22/2025 - The Fly
Income Statement
Total Revenue (TTM)
$673.96M
EBITDA (TTM)
$119.66M
EBIT (TTM)
$45.10M
Net Income (TTM)
-$13.83M
Balance Sheet
Total Assets (Q)
$2.90B
Total Debt (Q)
$686.06M
Total Liabilities (Q)
$839.89M
Book Value Per Share (Q)
$36.65
Cash Flow
Cash from Operations (TTM)
$132.11M
Cash from Investing (TTM)
-$152.57M
Cash from Financing (TTM)
-$83.32M
Net Change in Cash (TTM)
-$100.29M
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 17 and 21 (est)
Price History
Loading...
Beta
1.19
7-Day Total Return
19.58%
30-Day Total Return
19.61%
60-Day Total Return
16.68%
90-Day Total Return
16.57%
Year to Date Total Return
3.97%
1-Year Total Return
1.92%
2-Year Total Return
-7.62%
3-Year Total Return
-17.81%
5-Year Total Return
0.98%
52-week Low
Apr 07, 2025 - $102.97
52-week High
Jan 28, 2025 - $182.52
Valuation
Market Cap
$7.07B - Mid Cap
Enterprise Value
$7.04B
Price/Sales (TTM)
10.53
Price/Book (Q)
3.43
Dividends and Shares
Shares Outstanding
56.51
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.repligen.com
Phone Number
781 250 0111
Address
Building 1
Suite 100 - 41 Seyon Street
Waltham, MA 02453
Country
United States
Year Founded
1981
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers... more
NASDAQ 10/03/2025 4:00PM Eastern Quotes delayed